FJBYDYUFTIKFLT-CAMMJAKZSA-N
Compound with spectra: 1 NMR
| SpectraBase Compound ID | VkYqksC6dC |
|---|---|
| InChI | InChI=1S/C22H43N3O5Si2/c1-21(2,3)31(7,8)28-14-16-15(13-23)18(30-32(9,10)22(4,5)6)19(29-16)25-12-11-17(26)24-20(25)27/h11-12,15-16,18-19H,13-14,23H2,1-10H3,(H,24,26,27)/t15-,16-,18-,19-/m0/s1 |
| InChIKey | FJBYDYUFTIKFLT-CAMMJAKZSA-N |
| Mol Weight | 485.8 g/mol |
| Molecular Formula | C22H43N3O5Si2 |
| Exact Mass | 485.274125 g/mol |
| Enantiomer InChIKey | FJBYDYUFTIKFLT-PSBWJHGTSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3:CD3OD=19:1 |
1-[3-C-ALLYL-2,5-O-BIS-(TERT.-BUTYLDIMETHYLSILYL)-BETA-D-PENTOFURANOSYL]-URACYL
1-[2,5-O-BIS-(TERT.-BUTYLDIMETHYLSILYL)-3-C-CARBONYLMETHYL-BETA-D-PENTOFURANOSYL]-URACYL
1-[4-[tert-butyl(dimethyl)silyl]oxy-3-trimethylsilyloxy-5-(trimethylsilyloxymethyl)-2-oxolanyl]pyrimidine-2,4-dione
Uridine <5-methyl->, tri-TMS
Acetic acid, 4-acetoxy-2-[2-(acetylthio)ethyl]-5-(2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-yl)tetrahydrofuran-3-ylmethyl ester
1-[(2R,3R,4R,5R)-3,4-bis(trimethylsilyloxy)-5-(trimethylsilyloxymethyl)tetrahydrofuran-2-yl]-3-methyl-pyrimidine-2,4-dione
2'-URIDYLIC ACID, MIXTURE WITH 3'-URIDYLIC ACID, MONOHYDRATE
2'-URIDYLIC ACID, DISODIUM SALT, MIXTURE WITH 3'-URIDYLIC ACID, DISODIUM SALT, MONOHYDRATE
5'-O-(TERT.-BUTYLDIMETHYLSILYL)-URIDINE-2'-DEOXY-2'-ALPHA-C,3'-O-GAMMA-BUTYROLACTONE;2,3-DIHYDRO-[5'-O-(TERT.-BUTYLDIMETHYLSILYL)-2',3'-DIDEOXYURI
1-(3-Deoxy-3-C,2-O-<1-isopropyl-ethylene>-B-D-lyxofuranosyl)-uracil
| Title | Journal or Book | Year |
|---|---|---|
| Synthesis and Properties of RNA Analogues Having Amides as Interuridine Linkages at Selected Positions | Journal of the American Chemical Society | 2003 |
KnowItAll NMR Spectral Library
Author: Wiley
The KnowItAll NMR Spectral Library offers a comprehensive collection of NMR reference spectra, including NMR, CNMR, and XNMR, and covers a wide range of compounds including organics, polymers, monomers, metabolites, and more. Learn more.